Abhishek Mittal is a PhD Scholar at Amity Institute of Public Health, Amity University, Noida, India
Does BPC 157 increase testosterone in humans
We do not provide preparation, measurement or administration guidance under any circumstances, and enquiries indicating intended human use will be refused.
From topical research: Most commonly reported observation: mild transient redness at application site (attributed to vascular activity from VEGF stimulation) No systemic adverse events reported in human topical studies at standard concentrations No evidence of carcinogenicity or mutagenicity in available in vitro models From injectable research (preclinical): At supratherapeutic doses in animal models, mild injection site reactions have been noted No organ toxicity observed in standard preclinical safety panels No immunogenicity concerns identified (consistent with its endogenous structure) Copper considerations: GHK-Cu delivers a small amount of bioavailable copper
There is no FDA-approved adult or athletic indication for any IGF-1 product
Unopened GHK-Cu serum stored at 4C retains 8590% peptide activity for 912 months, while the same product stored at 25C loses 3040% activity within 6 months